TREATMENT OF METASTATIC STAGE PROSTATE CANCER WITH DEGARELIX

The invention provides uses and dosing regimens of a gonadotrophin releasing hormone (GnRH) antagonist for safely and effectively treating androgen-dependent prostate cancer without causing a testosterone spike and/or other side effect of GnRH agonist therapy such as a urinary tract infection, or an...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	PERSSON, Bo-Eric, CANTOR, Per, OLESEN, Tine Kold, VAN DER MEULEN, Egbert, A, JENSEN, Jens-Kristian Slott
Format:	Patent
Sprache:	eng ; fre ; ger
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The invention provides uses and dosing regimens of a gonadotrophin releasing hormone (GnRH) antagonist for safely and effectively treating androgen-dependent prostate cancer without causing a testosterone spike and/or other side effect of GnRH agonist therapy such as a urinary tract infection, or an arthralgia-related or cardiovascular side effect.